
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Shareholders Re-Elect Mahmud Haq and Cameron Munter, Approve Executive Compensation, Equity Incentive Plan and Independent Auditor SOMERSET, N. J. , June 05, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (Nasdaq: CCLD), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced the results of its 2026 Annual Shareholders' Meeting, held on June 4, 2026.

SOMERSET, N.J., June 05, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced the results of its 2026 Annual Shareholders' Meeting, held on June 4, 2026.

Acquisition opens a new growth opportunity, bringing trusted compliance, audit-defense, and regulatory expertise to CareCloud's more than 45,000 providers SOMERSET, N.J., May 26, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that it has acquired Empower Healthcare & Compliance Partners, LLC (“Empower”), a full-service healthcare compliance and advisory firm.

CareCloud, Inc. (CCLD) Analyst/Investor Day Transcript

SOMERSET, N.J., May 21, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions, today provided a recap of its 2026 Analyst Day, held on May 19, 2026, at the Nasdaq MarketSite in Times Square, New York City.

Company intends to access growth capital opportunistically only at or above $5.00 per share through its existing $60 million ATM facility SOMERSET, N.J., May 18, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD), (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced the full redemption of 100% of its outstanding 8.75% Series B Preferred Stock, marking a major milestone in the Company's multi-year transformation and capital structure evolution.

Capital Structure Simplification, AI Product Strategy, and Path to Sustainable Growth in Focus SOMERSET, N.J., May 11, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) ("CareCloud" or the "Company"), a leader in healthcare technology and AI-powered solutions, today announced it will host its 2026 Analyst Day on Tuesday, May 19, 2026, at the Nasdaq MarketSite in New York City.

CareCloud, Inc. (CCLD) Q1 2026 Earnings Call Transcript

CareCloud, Inc. (CCLD) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago.

Reaffirms Guidance Following Capital Structure Simplification; Revenue Grows 13% Year-Over-Year SOMERSET, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, today announced financial results for the quarter ended March 31, 2026.

CareCloud (CCLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SOMERSET, N.J., April 20, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the first quarter ended March 31, 2026 before the market opens on Thursday, May 7, 2026.

Here is how CareCloud, Inc. (CCLD) and CareDx (CDNA) have performed compared to their sector so far this year.

SOMERSET, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of AI-driven healthcare technology and revenue cycle management solutions, today reaffirmed its previously issued financial guidance following the successful closing of a $50 million credit facility and the announced redemption of 100% of its Series B Preferred Stock.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MSP Recovery (NASDAQ: MSPR - Get Free Report) and CareCloud (NASDAQ: CCLD - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends and institutional ownership. Earnings and Valuation This table compares MSP Recovery

Facility with Citizens Bank and Provident Bank underscores strong access to institutional capital SOMERSET, NJ, April 14, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of AI-driven healthcare technology and revenue cycle management solutions, today announced the closing of a $50 million credit facility on April 13, 2026, with Citizens Bank, N.A. (“Citizens”) and Provident Bank, a subsidiary of Provident Financial Services, Inc (“Provident Bank”).

SOMERSET, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of healthcare technology and AI-enabled revenue cycle management (“RCM”) solutions, today announced a new partnership with Arkansas Otolaryngology Center, P.A., one of the region's most respected Ear, Nose, Throat, Allergy, and Sleep practices. Based in Little Rock, the multi-location practice has selected CareCloud's AI-powered practice management and revenue cycle management solutions to streamline operations, accelerate revenue capture, and elevate the patient experience across Arkansas.

Here is how CareCloud, Inc. (CCLD) and Bicara Therapeutics Inc. (BCAX) have performed compared to their sector so far this year.

AI-Driven Physician Recruitment Will Deliver Faster Hiring and Measurable ROI SOMERSET, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO), (“CareCloud” or the “Company”), a leader in healthcare technology and AI-driven solutions, today announced it will present at the 2026 Association for Advancing Physician and Provider Recruitment (“AAPPR”) Annual Conference, April 13–15 in Orlando, Florida, while showcasing its Marketware physician strategy platform.

Healthcare technology giant CareCloud has confirmed that hackers accessed one of its stores of patients' electronic health records during a data breach earlier this month.

CareCloud, Inc. (NASDAQ: CCLD - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 13th, there was short interest totaling 784,771 shares, a growth of 39.0% from the February 26th total of 564,570 shares. Based on an average trading volume of 512,068 shares, the

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

SOMERSET, N.J., March 30, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of healthcare technology and revenue cycle management solutions, today highlighted the successful continued market absorption of the Q1 2025 conversion of its Series A Preferred Stock (“Preferred A”, formerly traded as CCLDP) into common equity, while reaffirming its previously issued financial guidance and continued confidence in its growth outlook.

SOMERSET, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced that the Company will attend the HFMA Revenue Cycle Conference in Arlington, Texas, where it will showcase the continued evolution of MAP App, its web-based revenue cycle benchmarking.

SOMERSET, N.J., March 17, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced that the Company will participate in the 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum on Tuesday, March 17, 2026.

Here is how CareCloud, Inc. (CCLD) and Caribou Biosciences, Inc. (CRBU) have performed compared to their sector so far this year.

SOMERSET, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of healthcare technology and revenue cycle management solutions, today announced that the Company will ring the Nasdaq Closing Bell on Tuesday, May 19, 2026, at the Nasdaq MarketSite in New York City.

CareCloud (NASDAQ: CCLD) executives emphasized accelerating profitability, stronger cash generation, and a broadened product footprint during the company's fourth-quarter and full-year 2025 earnings call, highlighting strategic acquisitions and what management described as early traction for its newly launched AI offerings. 2025 results: revenue growth, first full year of positive GAAP EPS since IPO CEO Stephen Snyder

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CareCloud, Inc. (CCLD) Q4 2025 Earnings Call Transcript

CareCloud, Inc. (CCLD) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.23 per share a year ago.

SOMERSET, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions, today announced financial results for the full year and quarter ended December 31, 2025.
